-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
N-[3-[5-(2-Chloro-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide, also known as Compound X, is an important molecule in the field of medicinal chemistry and drug discovery.
It is a sulfonamide derivative of the oligonucleotide-directed fluorescent drug E-Jet, which has been shown to be effective in the visualization of RNA structures in cells.
The synthesis of Compound X involves several steps, starting with the synthesis of the fluorescent moiety.
This is achieved through a sequence of reactions that involve the condensation of several different building blocks, including 4-thiazolyl-2-fluorophenyl chloride, 2-[1,1-dimethylethyl]-5-(4-nitrophenyl)pyrimidine, and potassium carbonate.
These reactions are typically carried out in a solvent such as acetonitrile or DMF, and are often performed in the presence of a catalyst such as triethylamine or pyridine.
Once the fluorescent moiety has been synthesized, the next step involves the synthesis of the sulfonamide group.
This is typically achieved through a reaction known as a sulfonation reaction, in which a sulfonate group is introduced onto the molecule.
This reaction is often carried out using a sulfonation agent such as potassium sulfate or sodium hydrogensulfate, in the presence of a solvent such as water or an organic solvent such as dichloromethane.
Finally, the synthesis of Compound X is completed through a reaction known as a Suzuki coupling reaction, in which a boronic acid derivative is introduced onto the molecule.
This reaction is typically carried out in the presence of a palladium catalyst, such as palladium acetate, and a phosphine ligand, such as triphenylphosphine.
The reaction is often performed in a solvent such as water or DMF, and typically involves the addition of a base such as sodium carbonate to facilitate the reaction.
Once the synthesis of Compound X has been completed, the molecule can be purified and characterized using a variety of techniques.
These may include high-performance liquid chromatography (HPLC), gas chromatography (GC), or mass spectrometry (MS).
Compound X has been shown to be effective in the visualization of RNA structures in cells, making it a valuable tool in the field of medicinal chemistry and drug discovery.
It has also been shown to have potential as a fluorescent probe for the study of RNA-protein interactions and RNA folding.
Overall, the synthesis of Compound X is a complex process that involves several steps, but can be carried out using a variety of readily available reagents and equipment.
The resulting molecule has important applications in the field of medicinal chemistry and drug discovery, and is a valuable tool for the study of RNA structures and interactions.